Aeluma, Inc. (NASDAQ: ALMU) announced that it has secured a NASA award to advance its integrated quantum dot laser platform for data communication and sensing applications. The award provides non‑dilutive funding that will accelerate the commercialization of the company’s technology and validate its platform with a high‑profile aerospace customer.
Aeluma’s platform delivers high‑power, low‑noise optical gain directly on silicon, enabling on‑chip optical amplification for AI data‑center interconnects and advanced sensing. The technology addresses a key limitation of silicon photonics by providing on‑chip optical gain while leveraging CMOS‑compatible manufacturing.
The award follows a November 2024 NASA contract for quantum‑dot photonic integrated circuits and more than $4 million in U.S. government contracts for semiconductor heterogeneous integration. Aeluma’s cash position stood at $38.1 million at the end of Q1 2026, and the company has guided full‑year 2026 revenue between $4 million and $6 million.
In the most recent quarter, Aeluma reported revenue of $1.4 million and a GAAP net loss of $1.5 million, compared with $1.3 million and a $859,000 loss in Q4 2025. The company’s financials reflect continued investment in research and development and scaling of its manufacturing process.
Founder and CEO Jonathan Klamkin said, "Interest in quantum dot lasers for datacom and sensing continues to grow. We are pleased to continue our collaboration with NASA to advance our integrated quantum dot laser platform. This award provides non‑dilutive funding to accelerate commercialization efforts and to strengthen our relationships with NASA and key manufacturing partners." The award is expected to accelerate commercialization and position Aeluma for future government and commercial opportunities.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.